Carbapenem-Resistant Acinetobacter baumannii Acquired Before Liver Transplantation: Impact on Recipient Outcomes

Imagem de Miniatura
Citações na Scopus
Tipo de produção
Data de publicação
Título da Revista
ISSN da Revista
Título do Volume
LIVER TRANSPLANTATION, v.22, n.5, p.615-626, 2016
Projetos de Pesquisa
Unidades Organizacionais
Infection with carbapenem-resistant Acinetobacter baumannii (CRAB) after liver transplantation (LT) is associated with high mortality. This study aimed to identify risk factors for post-LT CRAB infection, as well as to evaluate the impact of pre-LT CRAB acquisition on the incidence of post-LT CRAB infection. This was a prospective cohort study of all patients undergoing LT at our facility between October 2009 and October 2011. Surveillance cultures (SCs) were collected immediately before LT and weekly thereafter, until discharge. We analyzed 196 patients who were submitted to 222 LTs. CRAB was identified in 105 (53.6%); 24 (22.9%) of these patients were found to have acquired CRAB before LT, and 85 (81.0%) tested positive on SCs. Post-LT CRAB infection occurred in 56 (28.6%), the most common site being the surgical wound. Multivariate analysis showed that the risk factors for developing CRAB infection were prolonged cold ischemia, post-LT dialysis, LT due to fulminant hepatitis, and pre-LT CRAB acquisition with pre-LT CRAB acquisition showing a considerable trend toward significance (P = 0.06). Among the recipients with CRAB infection, 60-day mortality was 46.4%, significantly higher than among those without (P < 0.001). Mortality risk factors were post-LT infection with multidrug-resistant bacteria, LT performed because of fulminant hepatitis, retransplantation, prolonged cold ischemia, longer LT surgical time, and pre-LT CRAB acquisition, the last showing a trend toward significance (P = 0.08). In conclusion, pre-LT CRAB acquisition appears to increase the risk of post-LT CRAB infection, which has a negative impact on recipient survival.
  1. Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427
  2. Freire MP, 2015, TRANSPLANTATION, V99, P521, DOI 10.1097/TP.0000000000000381
  3. Bellier C, 2008, TRANSPL INT, V21, P755, DOI 10.1111/j.1432-2277.2008.00673.x
  4. Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010
  5. Freire MP, 2013, LIVER TRANSPLANT, V19, P1011, DOI 10.1002/lt.23682
  6. Marchaim D, 2007, J CLIN MICROBIOL, V45, P1551, DOI 10.1128/JCM.02424-06
  7. Freire MP, 2014, TRANSPL INFECT DIS, V16, P369, DOI 10.1111/tid.12210
  8. Kim YJ, 2014, TRANSPL P, V46, P828, DOI 10.1016/j.transproceed.2013.11.030
  9. Paugam-Burtz C, 2009, LIVER TRANSPLANT, V15, P522, DOI 10.1002/lt.21730
  10. Zhong L, 2012, J INFECTION, V64, P299, DOI 10.1016/j.jinf.2011.12.005
  11. Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
  12. Singh N, 2001, LIVER TRANSPLANT, V7, P100, DOI 10.1053/jlts.2001.21304
  13. Hsieh CE, 2013, TRANSPL P, V45, P225, DOI 10.1016/j.transproceed.2012.09.114
  14. Dalben MF, 2010, J HOSP INFECT, V74, P395, DOI 10.1016/j.jhin.2009.06.003
  15. Shi SH, 2009, TRANSPL INFECT DIS, V11, P405, DOI 10.1111/j.1399-3062.2009.00421.x
  16. Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005
  17. Martin EF, 2012, LIVER TRANSPLANT, V18, P914, DOI 10.1002/lt.23440
  18. Kim YJ, 2011, TRANSPL P, V43, P2397, DOI 10.1016/j.transproceed.2011.06.011
  19. Giamarellou H, 2008, INT J ANTIMICROB AG, V32, P106, DOI 10.1016/j.ijantimicag.2008.02.013
  20. Weintrob AC, 2010, INFECT CONT HOSP EP, V31, P330, DOI 10.1086/651304
  21. Bodro M, 2013, TRANSPLANTATION, V96, P843, DOI 10.1097/TP.0b013e3182a049fd
  22. Clinical and Laboratory Standard Institute, 2012, M100S22 CLSI
  23. desGouvea EF, 2012, BMC INFECT DIS, V12, P351
  24. Immordino G, 2014, TRANSPL P, V46, P2290, DOI 10.1016/j.transproceed.2014.07.039
  25. Morise Z, 2014, WORLD J GASTROENTERO, V20, P14381, DOI 10.3748/wjg.v20.i39.14381
  26. Shields RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052349
  27. Souli M, 2008, EUROSURVEILLANCE, V13, P19045
  28. vansDuin D, 2013, AM J TRANSPLANT S4, V13, P31
  29. Ye QF, 2014, TRANSPL INFECT DIS, V16, P767, DOI 10.1111/tid.12278